Targeted Treatment in Head–Neck Cancer
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Otolaryngology".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 365
Special Issue Editors
Interests: endoscopes; skull base; cancer; head and neck surgery; otolaryngology; larynx
Interests: head and neck cancer; robotic surgery; oropharyngeal cancer; laryngeal cancer; rare neoplasm in head and neck
Interests: head and neck oncology; major salivary glands surgery, laryngeal cancer; thyroid cancer; molecular biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue to explore the advancements and challenges in personalized and precision medicine approaches for the management of head and neck cancer. This Special Issue invites original research articles that delve into various aspects of targeted treatment for head–neck cancer. We encourage submissions focusing on novel targeted therapies, immunotherapy and other precision medicine approaches that address the unique characteristics of head and neck tumors.
We seek comprehensive research articles, clinical studies, experimental investigations and translational studies that shed light on the latest developments in targeted treatment within the field of head–neck cancer. However, please note that this Special Issue will not consider mini-reviews or case reports.
We look forward to receiving your submissions and contributing to the collective understanding of targeted treatment potential in improving outcomes for patients with head and neck cancer.
Dr. Jacopo Zocchi
Dr. Gerardo Petruzzi
Dr. Pietro De Luca
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- head and neck squamous cell carcinoma
- precision medicine
- targeted therapies
- immunotherapy
- tumor heterogeneity
- treatment response monitoring
